Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity (Q39612071)

13 September 2017

title

Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity (English)

1 reference

13 September 2017

1 reference

Yuanyuan Tian

1 reference

13 September 2017

Yuan Hu

1 reference

13 September 2017

Zengchan Wang

1 reference

13 September 2017

Ke Chen

1 reference

13 September 2017

Lei Zhang

1 reference

13 September 2017

Liying Wang

1 reference

13 September 2017

Min Ren

1 reference

13 September 2017

Ailong Huang

1 reference

13 September 2017

Hua Tang

1 reference

13 September 2017

publication date

5 January 2011

1 reference

13 September 2017

1 reference

inferred from page(s)

published in

Archives of Virology

1 reference

13 September 2017

volume

156

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

869-874

1 reference

Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Estimates of the worldwide incidence of 25 major cancers in 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

The hepatitis B virus large surface protein (LHBs) is a transcriptional activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

The enigmatic X gene of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Isotype-specific functions of Raf kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Kinases: positive and negative regulators of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Suppression of apoptosis: role in cell growth and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Increased MAPK expression and activity in primary human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Raf kinases: oncogenesis and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Bcl-2 targets the protein kinase Raf-1 to mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Raf kinase as a target for anticancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-010-0901-Z

10.1007/S00705-010-0901-Z

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference